These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30511288)

  • 1. Are Publicly Funded Health Databases Geographically Detailed and Timely Enough to Support Patient-Centered Outcomes Research?
    Min S; Martin LT; Rutter CM; Concannon TW
    J Gen Intern Med; 2019 Mar; 34(3):467-472. PubMed ID: 30511288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The case for a comparative, value-based alternative to the patient-centered outcomes research model for comparative effectiveness research.
    Marko NF; Weil RJ
    Neurosurg Focus; 2012 Jul; 33(1):E8. PubMed ID: 22746240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion.
    Law E; Harrington R; Alexander GC; Saha S; Oehrlein E; Perfetto EM
    J Comp Eff Res; 2018 Feb; 7(2):181-191. PubMed ID: 29465252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and patient-centered outcomes research: enhancing uptake and use by patients, clinicians and payers.
    Schumock GT; Pickard AS
    J Comp Eff Res; 2018 Feb; 7(2):177-180. PubMed ID: 29464965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward comparative effectiveness research and patient engagement among reproductive health clinicians.
    Kohn J; Unger Z; Dolatshahi J; Simons H; Rein A
    J Comp Eff Res; 2017 Jun; 6(4):337-345. PubMed ID: 28621553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in action: the role of passive personalization in comparative effectiveness research.
    Basu A; Jena AB; Goldman DP; Philipson TJ; Dubois R
    Health Econ; 2014 Mar; 23(3):359-73. PubMed ID: 24123568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of comparative effectiveness research on interventional pain management: evolution from Medicare Modernization Act to Patient Protection and Affordable Care Act and the Patient-Centered Outcomes Research Institute.
    Manchikanti L; Falco FJ; Benyamin RM; Helm S; Parr AT; Hirsch JA
    Pain Physician; 2011; 14(3):E249-82. PubMed ID: 21587337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can CER be an effective tool for change in the development and assessment of new drugs and technologies?
    Brixner DI; Watkins JB
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S06-11. PubMed ID: 22663293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is important to note that RWD will never replace the more traditional and more robust RCT data; however, the emerging trend is to incorporate data that are more generalizable. Introduction.
    Mullins CD; Sanchez RJ
    J Manag Care Pharm; 2011; 17(9 Suppl A):S03-4. PubMed ID: 22074667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data sources for heart failure comparative effectiveness research.
    Xian Y; Hammill BG; Curtis LH
    Heart Fail Clin; 2013 Jan; 9(1):1-13. PubMed ID: 23168313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness research in hand surgery.
    Johnson SP; Chung KC
    Hand Clin; 2014 Aug; 30(3):319-27, vi. PubMed ID: 25066850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. INTEGRATING COMMUNITY-LEVEL DATA RESOURCES FOR PRECISION MEDICINE RESEARCH.
    Bush WS; Crawford DC; Briggs F; Freedman D; Sloan C
    Pac Symp Biocomput; 2018; 23():618-622. PubMed ID: 29218920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. American Recovery and Reinvestment Act-comparative effectiveness research infrastructure investments: emerging data resources, tools and publications.
    Segal C; Holve E
    J Comp Eff Res; 2014 Nov; 3(6):647-55. PubMed ID: 25494571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Patient-Centered Outcomes Research Network: a national infrastructure for comparative effectiveness research.
    Califf RM
    N C Med J; 2014; 75(3):204-10. PubMed ID: 24830497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Futurescapes: evidence expectations in the USA for comparative effectiveness research for drugs in 2020.
    Messner DA; Mohr P; Towse A
    J Comp Eff Res; 2015 Aug; 4(4):385-400. PubMed ID: 25730709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bringing Patient-Centered Outcomes Research to Life.
    Borden WB; Chiang YP; Kronick R
    Value Health; 2015 Jun; 18(4):355-7. PubMed ID: 26091588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementing CER: what will it take?
    Biskupiak JE; Dunn JD; Holtorf AP
    J Manag Care Pharm; 2012 Jun; 18(5 Supp A):S19-29. PubMed ID: 22663296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tall order on a tight timeframe: stakeholder perspectives on comparative effectiveness research using electronic clinical data.
    Holve E; Lopez MH; Scott L; Segal C
    J Comp Eff Res; 2012 Sep; 1(5):441-51. PubMed ID: 24236421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and challenges for comparative effectiveness research (CER) with Electronic Clinical Data: a perspective from the EDM forum.
    Holve E; Segal C; Hamilton Lopez M
    Med Care; 2012 Jul; 50 Suppl():S11-8. PubMed ID: 22692252
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.